Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov-Dec;87(6):683-688.
doi: 10.1016/j.bjorl.2020.02.004. Epub 2020 Mar 19.

What is the effectiveness of beta-glucan for treatment of acute otitis media?

Affiliations

What is the effectiveness of beta-glucan for treatment of acute otitis media?

Erdem Atalay Cetinkaya et al. Braz J Otorhinolaryngol. 2021 Nov-Dec.

Abstract

Introduction: As a supplement, beta-glucan has various therapeutic healing effects generated by the immune cells. It has been scientifically approved and proven to be a biological defense modifier. The aim of this study was to investigate the effects of beta-glucan on treatments administered in an acute otitis media model OBJECTIVES: This study investigated the effect of beta-glucan on the treatment of acute otitis media in an acute otitis media -induced animal model. Efficacy was evaluated both immunologically and histologically.

Methods: The study sample comprised 35 adult rats, randomly separated into 5 groups of 7: Group 1 (control), Group 2 (acute otitis media, no treatment), Group 3 (acute otitis media+antibiotic), Group 4 (acute otitis media+beta-glucan) and Group 5 (acute otitis media+beta-glucan+antibiotic). Analyses were made of the histopathology and immunology examination results in respect of thickening of the tympanic membrane, epithelium damage, inflammation, and sclerosis. In all groups the serum levels of TNF-α, IL-4, IL-6 and IL-1β were evaluated.

Results: All serum cytokine levels were significantly lower in the beta-glucan and antibiotic-treated groups compared to the acute otitis media Group. Significant differences in tympanic membrane thickness, inflammation, epithelium damage, and sclerosis values were observed between the acute otitis media+antibiotic and acute otitis media+beta-glucan Groups. According to these parameters, the values in aute otitis media+antibiotic+beta-glucan Group were markedly lower than those of the other groups. There was a significant difference in the acute otitis media+antibiotic+beta-glucan Groups compared to acute otitis media Group (p < 0.001).

Conclusions: Both antibiotic and beta-glucan treatment reduced acute otitis media signs of inflammations in an acute otitis media-induced rat model, decreasing histological damage and cytokine levels. Co-administration of antibiotic and beta-glucan led to a significant reduction in tympanic membrane thickness, inflammation, and epithelium damage. Antibiotic+beta-glucan treatment resulted in a greater decrease in tympanic membrane thickness, inflammation, and epithelium damage than in the other groups. From these results, it can be suggested that beta-glucan, in combination with antibiotics may provide an alternative for the treatment of acute otitis media.

Keywords: Acute otitis media; Beta Glucan; Cytokines; Histological examination; Rats.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Control group, Tympanic membrane structure and malleus attached to membrane; H&E ×100. (EAC, External Auditory Canal; TC, Tympanic Cavity; TM, Tympanic Membrane; M, Malleus; H&E, Hematoxylin and Eosin).
Fig. 2
Fig. 2
AOM Group. ThicTM, DamEpith, Inf, (arrow) of the connective tissue and sc (head arrow), exuda (e), ThicTM (score +3), DamEpith (score +3), Inf, and Sc (score +3). H&E ×100.
Fig. 3
Fig. 3
AOM + Antibiotic group. The marked decrease in ThicTM, DamEpith, Inf and Sc (head arrow), H&E ×100.
Fig. 4
Fig. 4
AOM+β‒G Group. The marked decrease in ThicTM, DamEpith and Inf (arrow), H&E ×100.
Fig. 5
Fig. 5
AOM + antibiotic+β‒G Group. The marked decrease in ThicTM, Inf and Sc (head arrow), DamEpith (cut arrow), H&E ×400.

References

    1. Harker L.A., Shelton C. In: Otolaryngology-Head and Neck Surgery. 4th edn. Cummings C.W., Flint P.W., Harker L.A., Haughey B.H., Richardson M.A., Robbins K.T., editors. Elsevier Mosby; Philadelphia: 2005. Complication of temporal bone infections; pp. 3015–3016.
    1. Sidell D., Shapiro N.L., Bhattacharyya N. Obesity and the risk of chronic rhinosinusitis, allergic rhinitis, and acute otitis media in school-age children. Laryngoscope. 2013;123:2360–2363. - PubMed
    1. Penido Nde O., Chandrasekhar S.S., Borin A., Maranhão A.S., Gurgel T. Complications of otitis media ‒ a potentially lethal problem still present. Braz J Otorhinolaryngol. 2016;82:253–262. - PMC - PubMed
    1. Spektor Z., Pumarola F., Ismail K., Lanier B., Hussain I., Ansley J., et al. Efficacy and safety of ciprofloxacin plus fluocinolone in otitis media with tympanostomy tubes in pediatric patients: a randomized clinical trial. JAMA Otolaryngol Head Neck Surg. 2017;143:341–349. - PubMed
    1. Tapiainen T., Kujala T., Renko M., Koivunen P., Kontiokari T., Kristo A., et al. Effect of antimicrobial treatment of acute otitis media on the daily disappearance of middle ear effusion: a placebo-controlled trial. JAMA Pediatr. 2014;168:635–641. - PubMed